Basit öğe kaydını göster

dc.contributor.authorSari, Murat
dc.contributor.authorNalcaci, Meliha
dc.contributor.authorSari, Selma
dc.date.accessioned2021-03-03T20:03:03Z
dc.date.available2021-03-03T20:03:03Z
dc.date.issued2017
dc.identifier.citationSari M., Sari S., Nalcaci M., "The Effect of Suppressed Levels of Uninvolved Immunoglobulins on the Prognosis of Symptomatic Multiple Myeloma", TURKISH JOURNAL OF HEMATOLOGY, cilt.34, sa.2, ss.131-136, 2017
dc.identifier.issn1300-7777
dc.identifier.otherav_57d0d0bd-438e-4d15-bbfd-1dff72f700d1
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/61890
dc.identifier.urihttps://doi.org/10.4274/tjh.2016.0161
dc.description.abstractObjective: The majority of multiple myeloma (MM) patients have high levels of monoclonal immunoglobulin in the serum and/or urine and suppressed levels of the uninvolved immunoglobulins. The prognostic significance of this phenomenon has not been assessed sufficiently. In this study, our aim is to evaluate the prognostic significance of uninvolved immunoglobulin suppression measured by nephelometry in patients with new symptomatic MM and the association with other features of the disease.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectHematoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectHEMATOLOJİ
dc.titleThe Effect of Suppressed Levels of Uninvolved Immunoglobulins on the Prognosis of Symptomatic Multiple Myeloma
dc.typeMakale
dc.relation.journalTURKISH JOURNAL OF HEMATOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume34
dc.identifier.issue2
dc.identifier.startpage131
dc.identifier.endpage136
dc.contributor.firstauthorID243065


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster